Abstract
The lectin pathway provides an antibody independent route of complement activation. Mannan-binding lectin (MBL) can form compound with MBL-associated serine proteases (MASPs) through its collagen-like region (CLR) to initiate complement fixation. In this study, we designed and synthesized a range of peptides according to the sequence of CLR in human MBL, which were assumed to block the MBL-MASP interaction, in order to locate the serine protease binding motifs on human MBL. It was demonstrated that MASPs bind on the C-terminal side of the hinge region formed by an interruption in the Gly-X-Y repeat pattern of the collagen-like domain. In addition, Arg32Cys, Gly35Asp and Gly37Glu mutant proteins have the similar serine protease binding characteristic with wild type MBL, but the binding between mutated MBL proteins and MASPs is much weaker than that between wild type MBL protein and MASPs.
Keywords: Mannan-binding lectin (MBL), collagen-like region (CLR), interruption, MBL-associated serine proteases (MASPs), binding motifs, synthetic peptides
Protein & Peptide Letters
Title: Location of MBL-Associated Serine Proteases Binding Motifs on Human Mannan-Binding Lectin (MBL)
Volume: 17 Issue: 1
Author(s): Daming Zuo, Xuemin Cai, Na Zhao, Liyun Zhang and Zhengliang Chen
Affiliation:
Keywords: Mannan-binding lectin (MBL), collagen-like region (CLR), interruption, MBL-associated serine proteases (MASPs), binding motifs, synthetic peptides
Abstract: The lectin pathway provides an antibody independent route of complement activation. Mannan-binding lectin (MBL) can form compound with MBL-associated serine proteases (MASPs) through its collagen-like region (CLR) to initiate complement fixation. In this study, we designed and synthesized a range of peptides according to the sequence of CLR in human MBL, which were assumed to block the MBL-MASP interaction, in order to locate the serine protease binding motifs on human MBL. It was demonstrated that MASPs bind on the C-terminal side of the hinge region formed by an interruption in the Gly-X-Y repeat pattern of the collagen-like domain. In addition, Arg32Cys, Gly35Asp and Gly37Glu mutant proteins have the similar serine protease binding characteristic with wild type MBL, but the binding between mutated MBL proteins and MASPs is much weaker than that between wild type MBL protein and MASPs.
Export Options
About this article
Cite this article as:
Zuo Daming, Cai Xuemin, Zhao Na, Zhang Liyun and Chen Zhengliang, Location of MBL-Associated Serine Proteases Binding Motifs on Human Mannan-Binding Lectin (MBL), Protein & Peptide Letters 2010; 17 (1) . https://dx.doi.org/10.2174/092986610789909566
DOI https://dx.doi.org/10.2174/092986610789909566 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toxicogenomics to Improve Comprehension of the Mechanisms Underlying Responses of In Vitro and In Vivo Systems to Nanomaterials: A Review
Current Genomics Proteomic Analysis of the Kidney in Rat Biliary Cirrhosis
Current Proteomics Improved Mouse Models of Allergy and Allergic Asthma - Chances Beyond Ovalbumin
Current Drug Targets High Content Pharmacophores from Molecular Fields: A Biologically Relevant Method for Comparing and Understanding Ligands
Current Computer-Aided Drug Design Analysis of Trends and Opportunities of Anti-Allergy Patents in China from 1998 to 2008
Recent Patents on Inflammation & Allergy Drug Discovery Amniotic Fluid Embolism: Review
Current Pharmaceutical Biotechnology Novel Mast Cell-Stabilising Amine Derivatives of 3,4-Dihydronaphthalen-1(2H)-one and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one
Medicinal Chemistry Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion
Current Pharmaceutical Design Exploring Confluence-Related Signalling to Modulate the Expression of Oct4 – A Role in Facilitating Mouse Somatic Cell Reprogramming?
Current Stem Cell Research & Therapy Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Current Drug Targets About Mechanism of Gas Transport Function and Side Reactions of Perfluorocarbon Nano-dispersions
Current Bionanotechnology (Discontinued) Anti-arthritic Effect and Underlying Mechanism of Ginsenoside Metabolite Compound K
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy New Chalcone Derivative: Synthesis, Characterization, Computational Studies and Antioxidant Activity
Letters in Organic Chemistry Non-Cardiomyocytes in Heart Regeneration
Current Drug Targets Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Current Cancer Drug Targets First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties
Current Topics in Medicinal Chemistry Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition.
Current Medicinal Chemistry TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters